Introduction {#s1}
============

In the transition period of dairy cows, which includes 3 weeks pre- and 3 weeks postpartum, there is a high demand for nutrients and a decrease in feed ingestion, producing a transient negative energy balance ([@B1]). This period is characterized by hypoglycemia, mobilization of non-esterified fatty acids (NEFAs), and an increase in plasma beta-hydroxybutyrate levels ([@B2], [@B3]). Several studies have shown that NEFA values in plasma increase progressively, peaking at 0.7 mM and in some cases reaching concentrations \>1.5 mM during parturition ([@B3]--[@B5]). Moreover, around the time of parturition, high-yielding cows are predisposed to infectious diseases such as metritis ([@B6]) and mastitis ([@B7]), which is associated with an impaired innate immune response. Cows with high blood levels of NEFAs during peripartum have altered polymorphonuclear (PMN) trafficking and phagocytosis, as well as a reduced ability to kill microorganisms ([@B8]). This suggests that NEFAs can contribute to the modulation of the innate immune response, leading to the onset of metabolic and infectious diseases ([@B8], [@B9]).

Polymorphonuclear leukocytes cells (PMN) are the principal cell type of the host innate immune system and are regarded as the first line of defense against pathogens ([@B10]). PMN kill invading microorganisms primarily through three mechanisms: (1) phagocytosis and activation of NADPH oxidase with reactive oxygen species (ROS) production; (2) release of enzymes with proteolytic and bactericidal activities; and (3) release of fibers composed mainly of DNA, called neutrophil extracellular traps (NETs) ([@B10], [@B11]). Depending on the origin of the stimulus, NET production may or may not be dependent on NADPH oxidase activation ([@B12]). OA is a long-chain, monounsaturated fatty acid while LA is a long-chain, polyunsaturated fatty acid, and the levels of both NEFAs increase during the transition period in dairy cows ([@B13]). Both fatty acids are natural ligands for free fatty acid receptor 1 (FFAR1/GPR40), which is expressed in bovine PMN ([@B14]--[@B16]). Studies have shown that NEFAs activate bovine PMN responses *in vitro*. For instance, OA is reported to induce intracellular calcium mobilization, MAPK phosphorylation, superoxide production, and release of granules containing CD11b and MMP-9 ([@B14], [@B16]). Moreover, LA is known to increase MMP-9 release, stimulate PMN adhesion to endothelium, mobilize intracellular calcium, and activate signaling pathways such as ERK1/2 and p38 MAPK ([@B17]). However, the effects of OA and LA on NET production in cows are poorly understood.

In most mammalian cells, mitochondria are the main site for the aerobic oxidation of glucose and fatty acids, consumption of oxygen, and generation of ROS and ATP ([@B18], [@B19]). However, PMN have a few mitochondria and depend primarily on glycolysis for ATP production ([@B20], [@B21]). Besides being the primary source of cellular energy, ATP released into the extracellular space can also serve as important messenger molecules, facilitating communication between adjacent cells ([@B21]). Furthermore, extracellular ATP can serve as an autocrine signaling molecule through the activation of purinergic receptors ([@B22]). NET formation is known to require ATP production through glycolysis ([@B23]). Consistent with this, the mRNA expression of *P2X7, P2Y2*, and *P2Y11* was increased, whereas that of pannexin 1 (*PANX1*) was decreased, in bovine PMN 3 days postpartum ([@B24]), suggesting that ATP release and activation of purinergic receptors could be involved in bovine PMN activation in the peripartum period. Although fatty acids can induce an increase in the release of ATP ([@B25]), a few studies have investigated the effect of this nucleotide on bovine PMN activation.

Here, we examined whether purinergic signaling contributes to the increase in OA- and LA-induced NET release in bovine PMN. We observed that OA and LA increase ATP release through PANX1, contributing to the upregulation in NET production. In addition, our results support that beta-oxidation has an essential role in OA- and LA-induced NET extrusion, which suggests that fatty acid metabolism participates in the modulation of PMN responses.

Materials and Methods {#s2}
=====================

Animals
-------

Four Holstein Friesian heifers with body weights of 280--310 kg from the herd of the University Austral of Chile were used for the experiments. The heifers were fed twice a day with 1.0 kg of commercial concentrate, Cosetan® (IANSAGRO S.A., Chile), and grazed in naturalized pastures composed of *Holcus lanatus* and *Agrotis capillaris* pastures. Furthermore, a low contribution of forage legumes was administered, \<10% of dry matter, and water *ad libitum*. All experiments were performed in strict accordance with protocols approved by the ethical committee of the Universidad Austral de Chile (permit number: 281/2017) and according to the current Chilean Animal Protection Laws.

PMN Isolation
-------------

Blood was collected aseptically by jugular venipuncture into BD Vacutainer® tubes (Becton Dickinson, San Jose, CA, USA) containing acid citrate dextrose (ACD). The tubes were gently shaken for 5 min and then centrifuged at 1,000 × *g* for 20 min at 20°C. The plasma and buffy coat layers were aspirated and discarded, while the remaining red blood cells and PMN were resuspended in cold Hank\'s Balanced Salt Solution (HBSS; 5.0 mM KCl, 0.4 mM KH~2~PO~4~, 0.136 M NaCl, 0.3 mM Na~2~HPO~4~, and 0.6 mM D-glucose at pH 7.4). Blood was transferred to Falcon tubes (15 ml) and centrifuged again at 1,000 × *g* for 20 min at 20°C, and the remaining phlogistic layer was removed by aspiration with a Pasteur pipette. The erythrocytes were then separated twice by rapid hypotonic lysis with a cold, aqueous phosphate buffer solution (5.5 mM NaH~2~PO~4~ and 8.4 mM HK~2~PO~4~ at pH 7.2) in a 2:1 ratio. Next, isotonicity was restored with a solution of hypertonic phosphate (5.5 mM NaH~2~PO~4~, 8.4 mM HK~2~PO~4~, and 0.46 mM NaCl at pH 7.2) in a 1:1 ratio, and then centrifuged at 600 × *g* for 10 min at 20°C. The PMN pellet was resuspended and washed twice with cold HBSS, being centrifuged each time at 500 × *g* for 10 min at 20°C. Finally, the pellet was resuspended in 10 ml of cold HBSS and 100 μl of cells was incubated with 5 μM propidium iodide (Molecular Probes, Invitrogen, Carlsbad, CA, USA) in HBSS with Ca^2+^ for 5 min at room temperature (RT). After incubation, 900 μl of HBSS with Ca^2+^ was added, and purity, counts, and viability were assessed using flow cytometry (BD Accuri ™---BD, Franklin Lakes, NJ, USA; \>94% purity and viability were used as thresholds for performing the experiments).

Quantification of NETs by Fluorescence
--------------------------------------

PMN (1 × 10^6^) were suspended in HBSS with Ca^2+^ (0.897 mM) and exposed to 1 μM NF449 (P2X1 receptor antagonist; Tocris, Bristol, UK) ([@B26]), 10 μM carboxenolone (PANX1 inhibitor; Tocris) that was previously tested with different concentrations reported from former authors ([@B27], [@B28]), 0.1--50 μM 5-BDBD (P2X4 receptor antagonist; Tocris) ([@B29]), 0.001--10 μM A804598 (P2X7 receptor antagonist; Tocris) ([@B30]), 10 μM GW1100 (selective FFAR1 antagonist) ([@B15], [@B16]), and 10 μM DPI (NADPH oxidase inhibitor) ([@B31]) for 15 min at 37°C, except 5-BDBD that was incubated for 45 min, or 10 μM etomoxir \[inhibitor of carnitine palmitoyltransferase-1 (CPT-1); Cayman Chemical, Ann Arbor, MI, USA\] ([@B32]) for 60 min at 37°C. Then, OA (10--300 μM), LA (10--300 μM), or vehicle (0.01% DMSO) ([@B15], [@B16]), was added followed by incubation at 37°C for 30 min. Micrococcal nucleases (5 U/tube; New England Biolabs, Ipswich, MA, USA) were added and the PMN were incubated for 30 min. Then, the tubes were centrifuged at 800 × *g* for 6 min and 100 μl of the supernatant was transferred into transparent 96-well plates. Finally, 50 μl of PicoGreen (1:200, in HBSS with Ca^2+^; Invitrogen) was added. NETs were quantified using 485/520 nm excitation/emission wavelengths in a Thermo Scientific Varioskan Flash (Thermo Scientific, Waltham, MA, USA) and expressed as relative fluorescence units (RFUs). Measurements were performed in duplicate.

Visualization of NET Release
----------------------------

PMN (2 × 10^5^) were preincubated with NF449 (1 μM) or carboxenolone (10 μM) for 15 min at 37°C, or with 10 μM etomoxir for 60 min at 37°C, and then stimulated with 300 μM OA or LA for 30 min. The PMN were fixed in a 2% paraformaldehyde solution for 30 min at RT, followed by blocking with a 1% BSA solution for 2 h, and incubation with an anti-histone H4 (citrulline 3) antibody (\#07-596, Meck Millipore, Darmstadt, Germany) overnight at 4°C. The next day, samples were washed three times with sterile HBSS and incubated with an Alexa Fluor 405- or Alexa Fluor 488-conjugated anti-rabbit secondary antibody (\#A31556 or A11055, Thermo Fisher Scientific, Waltham, MA, USA) for 2 h at RT. To visualize the nuclei, the covers were stained with PicoGreen (1:200 in HBSS with Ca^2+^) or Sytox Orange (5 μM in HBSS with Ca^2+^; \#S34861, Thermo Fisher Scientific) for 30 min at RT. Images were acquired with a confocal microscope (Fluoview FV1000; Olympus, Tokyo, Japan).

Quantification of ATP Levels
----------------------------

ATP levels were determined using a commercial ATP Determination Kit (\#A22066, Thermo Fisher Scientific). PMN (5 × 10^5^) were resuspended in 250 μl of HBSS with Ca^2+^ and treated in two sets of experiments. In the first set, PMN were stimulated with 200 μM OA or LA, or vehicle (0.088% DMSO) for 0, 15, 30, or 60 s to obtain the time of the maximum ATP release for both NEFAs (**Figure 2**). In the second set, the PMN were treated with 10 μM carbenoxolone (CBX) or vehicle (0.01% DMSO) for 15 min at 37°C and then were stimulated with 300 μM OA or LA, or vehicle (0.088% DMSO) for 15 s (**Figures 3C,D**). Immediately after finishing the time of stimulation, the PMN were maintained on ice for 5 min. Subsequently, the cells were centrifuged at 600 × *g* for 5 min at 4°C. A 10-μl aliquot of the supernatant was incubated in 100 μl of the kit mix for the determination of ATP levels, according to the manufacturer\'s instructions. Finally, the samples were incubated at RT for 15 min, and the luminescence was measured using Varioskan Flash (Thermo Fisher Scientific). The data were normalized using the mean of 60 s of measurement of the control group.

RT-qPCR
-------

Total RNA was isolated from 5 × 10^6^ PMN per animal using EZNA Total RNA Kits (E.Z.N.A; Promega, Madison, WI, USA). Samples were treated with Turbo DNase-Free (Thermo Fisher Scientific). For cDNA synthesis, 500 ng of total RNA was reverse-transcribed using M-MLV Reverse Transcriptase Kits (Invitrogen, Thermo Fisher Scientific). Real-time PCR assays were performed using Takyon Rox SYBR® MasterMix dTTP Blue (Eurogentec, Fremont, CA, USA) and primers specific for bovine *P2X1*--*7, PANX1*, gap junction protein alpha 1 (*GJA1*), and housekeeping ribonucleoprotein S9 (*RPS9*). The primers used for the PCR reaction were as follows: P2X1 forward 5′-CTGTGCAGAGAACCCGGAAG−3′ and reverse 5′-CGTTGAAGGCCACACACTTG-3′; P2X2 forward 5′-GCGTTCTGGGACTACGAGAC-3′ and reverse 5′-CACGATGAACACGTACCACAC-3′; P2X3 forward 5′-CTACTTCGTGGGGTGGGTTT-3′ and reverse 5′-ATGACTCGGTTGGCATAGCG-3′; P2X4 forward 5′-GGTGCGTGTCATTCAATGGG-3′ and reverse 5′-AAAGCAGGCTTTGGCACTTC-3′; P2X5 forward 5′-GGGAGTGGGGTCTTTCTTCTG-3′ and reverse 5′-TTCACCTTTCCGTTCCCCTG-3′, P2X6 forward 5′-AACTTCAGGACAGCCACACA-3′ and reverse 5′-TGACCAGGATGTCGAAACGG-3′; P2X7 forward 5′-GCTGCAGCTGGAATGATGTTT-3′ and reverse 5′-AAAGAGCACCACGTGGAAGAG-3′; PANX1 forward 5′-TTGACTTGAGAGACGGTGCC-3′ and reverse 5′-TGGCTTTCCTGTGAACTTTGC-3′; GJA1 forward 5′-GAGTGCCTGGGCTTGCTTTT-3′ and reverse 5′-TTGCCTGGGTACTGCTCTTTCT-3′; and RSP9 forward 5′-GCTGACGCTGGATGAGAAAGACCC-3′ and reverse 5′-ATCCAGCACCCCGATACGGACG-3′. The following conditions were used on a StepOne Plus real-time PCR system (Thermo Fisher Scientific): one cycle at 95°C for 10 min and 35 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. This was followed by analysis of dissociation (melting) curves to ensure primer specificity. Relative changes in gene expression were determined by the Δ^CT^ method ([@B33]). The efficiency of primers was obtained through StepOne software v2.3 (R^2^, Slope and percentage efficiency), and the efficiency was calculated as \[10^(−1/slope)^\]. To P2X1 R^2^ = 0.96; Slope = −3.30; % efficiency = 100%, and efficiency was 2.01. To P2X4 R^2^ = 0.99; Slope = −3.40; % efficiency = 95%, and efficiency was 1.97. To P2X5 R^2^ = 0.96; Slope = −3.50; % efficiency = 110%, and efficiency was 1.93. To P2X7 R^2^ = 0.99; Slope = −3.03; % efficiency = 110%, and efficiency was 2.14. Finally, to PANX1 R^2^ = 0.99; Slope = −3.30; % efficiency = 100%, and efficiency was 2.01.

Statistical Analysis
--------------------

The results are illustrated in bar graphs or dot plots as means ± S.E.M. of four independent experiments. One-way analysis of variance (ANOVA) was performed, and Fisher\'s LSD multiple comparison test was applied, using a significance level of 5%. When assumptions of normality or homogeneity of variance were not met according to the Shapiro--Wilks or Brown--Forsythe test, respectively, Kruskal--Wallis ANOVA and Dunn\'s multiple comparison test were used. All statistical analyses were performed using GraphPad Prism v7.0 (GraphPad Software, La Jolla, CA, USA). A *p*-value \< 0.05 was considered significant.

Results {#s3}
=======

Oleic Acid and Linoleic Acid Induced NET Formation in Bovine PMN
----------------------------------------------------------------

Exposure to 200 and 300 μM OA ([Figures 1A,C](#F1){ref-type="fig"}) or LA ([Figures 1B,D](#F1){ref-type="fig"}) increased NET formation after 30 min of stimulation. Moreover, the increase in NET formation induced by 300 μM OA and LA was completely abolished in the presence of DNase I (data not shown). To evaluate the mechanism by which OA and LA induce NET formation, PMN were exposed to GW1100, a selective FFA1 antagonist. The results showed that GW1100 treatment did not affect the OA- or LA-induced production of NETs ([Figures 1E,F](#F1){ref-type="fig"}). Similarly, when PMN were incubated with DPI, a NADPH oxidase inhibitor, OA- or LA-induced NET formation was not affected ([Figures 1G,H](#F1){ref-type="fig"}). These results suggested that the formation of NETs that was induced by short-term culturing with these fatty acids was independent of FFA1 and NADPH oxidase.

![Oleic acid (OA) and linoleic acid (LA) induce neutrophil extracellular trap (NET) formation independently of FFAR1 and NADPH oxidase activation. Bar graph (means ± S.E.M.) showing the relative fluorescence (RFU) of cell-free (cf)-DNA obtained from PMN treated with different concentrations of OA **(A)** or LA **(B)**. Immunofluorescence of PMN treated with a 300 μM concentration of OA **(C)** or LA **(D)** using an anti-histone H4 citrulline 3 antibody as a NET marker and Sytox orange as a DNA marker. Images are representative of four independent experiments; scale bar = 20 μM. Bar graph of RFU (means ± S.E.M.) of cf-DNA obtained from PMN treated with GW1100 (FFAR1 antagonist) **(E,F)** or diphenyleneiodonium (DPI) **(G,H)** for 15 min and then stimulated for 30 min with OA or LA. *n* = 4; \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001 compared with vehicle controls.](fvets-07-00260-g0001){#F1}

An Increase in Extracellular ATP Levels Induced by Oleic Acid and Linoleic Acid Modulates NET Production
--------------------------------------------------------------------------------------------------------

To assess the mechanism associated with OA- or LA-induced NET formation, we measured the concentrations of extracellular ATP released within 60 s by PMN stimulated with 200 μM of both fatty acids. Our results showed that OA and LA induced a peak of ATP release between 15 and 30 s ([Figure 2](#F2){ref-type="fig"}).

![Oleic acid (OA) and linoleic acid (LA) induce ATP release. Levels of released ATP in supernatants of PMN treated with a 200 μM concentration of OA **(A)** or LA **(B)** for 0, 15, 30, and 60 s. The data were normalized using the mean of 60 s of measurement of control group. *n* = 4; \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 compared with vehicle controls.](fvets-07-00260-g0002){#F2}

Pannexin-1 is an ATP release channel with important roles in both paracrine and autocrine ATP signaling ([@B34]). We found that *PANX1* mRNA was expressed in bovine PMN ([Figures 3A,B](#F3){ref-type="fig"}). Furthermore, exposure to the PANX1 inhibitor CBX significantly decreased the levels of extracellular ATP induced by OA or LA ([Figures 3C,D](#F3){ref-type="fig"}). These results suggest that both fatty acids induce an increase in extracellular ATP levels, and that this ATP is released through PANX1 in bovine PMN.

![Non-esterified fatty acid (NEFA)-induced ATP release is mediated *via* PANX1. Relative expression of *PANX1* to RPS9 (housekeeping) in bovine PMN assessed by RT-qPCR **(A)**, *n* = 4. Gel of mRNA amplicons of *PANX1, GJA1*, and *RPS9* **(B)**. N.D.: not detected. bp: base pair. RT+, RT--: reverse transcriptase +, reverse transcriptase -. Bar graph showing ATP release from PMN treated with 10 μM carbenoxolone (CBX) for 15 min and then stimulated with oleic acid (OA) **(C)** or linoleic acid (LA) **(D)** for 30 min. *n* = 4; \**p* \< 0.05, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001 compared with vehicle controls.](fvets-07-00260-g0003){#F3}

ATP is an important extracellular ligand involved in autocrine signaling in PMN ([@B35]). To assess whether the PANX1-mediated increase in extracellular ATP levels is involved in fatty acid--induced NET formation, we evaluated the effect of CBX on NET production. We observed a significant decrease in OA- ([Figure 4A](#F4){ref-type="fig"}) and LA-induced ([Figure 4B](#F4){ref-type="fig"}) NET production in the presence of CBX. Similarly, cotreatment with CBX and either OA ([Figure 4C](#F4){ref-type="fig"}) or LA ([Figure 4D](#F4){ref-type="fig"}) led to a reduced number of structures such as NETs decorated with histone H4 citrulline 3 (H4Cit3) when compared with OA or LA treatment alone. All these results suggested that OA and LA induced ATP release and increased NET production through an autocrine signal.

![Oleic acid (OA) and linoleic acid (LA) induce neutrophil extracellular trap (NET) formation via PANX1-mediated ATP release. Bar graph (means ± S.E.M.) of cell-free (cf)-DNA of PMN treated with 10 μM carbenoxolone (CBX) for 15 min and stimulated or not with OA **(A)** or LA **(B)**. *n* = 4; \*\**p* \< 0.01, \*\*\**p* \< 0.001 compared with OA or LA treatment alone. Representative image from four independent experiments of PMN treated with CBX and stimulated with OA or LA **(C)**.](fvets-07-00260-g0004){#F4}

Expression of Purinergic P2X Receptors in Bovine PMN and Their Participation in NEFA-Induced NET Formation
----------------------------------------------------------------------------------------------------------

Recently, it was shown that extracellular ATP release by proinflammatory mediators can modulate PMN responses in an autocrine manner through the activation of the purinergic P2X receptor family members ([@B21], [@B22]). Therefore, we evaluated the expression of purinergic P2X receptors in bovine PMN. We found that *P2X1, P2X4, P2X5*, and *P2X7* were expressed in bovine PMN; however, the expression of *P2X1* and *P2X4* was higher than that of *P2X5* and *P2X7* ([Figures 5A,B](#F5){ref-type="fig"}). To confirm the autocrine effect of ATP on the NEFA-induced production of NETs in bovine PMN, we evaluated the role of purinergic receptors in NET production using pharmacological inhibitors of P2X1, P2X4, and P2X7. We first determined the optimal inhibitory concentrations of the three antagonists and observed that treatment with NF449, a P2X1 inhibitor, significantly decreased the OA-induced release of cf-DNA at the concentrations of 1 and 0.5 μM ([Supplementary Figure 1A](#SM1){ref-type="supplementary-material"}). However, treatment with the P2X4 ([Supplementary Figure 1B](#SM1){ref-type="supplementary-material"}) and P2X7 ([Supplementary Figure 1C](#SM1){ref-type="supplementary-material"}) receptor inhibitors did not interfere cf-DNA release. Similarly, we did not observe any effect of the P2X4 and P2X7 antagonists with LA (data not shown). We did not test the effect of P2X5 on cf-DNA release as no specific antagonist for this receptor is yet available. Consistent with this finding, bovine PMN treated with 1 μM NF449 and exposed to OA or LA decreased cf-DNA release ([Figures 6A,B](#F6){ref-type="fig"}) and NET formation ([Figure 6C](#F6){ref-type="fig"}), compared with OA or LA treatment. These results suggest that exposure to NEFAs increases the production of NETs *via* the activation of purinergic signaling through P2X1 in bovine PMN.

![mRNA expression of the P2X receptor in bovine PMN. Relative expression of *P2X1*--*7* to RPS9 (housekeeping) in bovine PMN **(A)**. Representative image of PCR amplicons of P2X receptors **(B)**. N.D., not detected.; bp, base pair; ST, standard of bp; RT+, RT--, reverse transcriptase +, reverse transcriptase --. *N* = 4.](fvets-07-00260-g0005){#F5}

![P2X1 is involved in oleic acid (OA)-induced neutrophil extracellular trap (NET) formation. Bar graph (means ± S.E.M.) of cf-DNA of PMN treated with 1 μM NF449 for 15 min and stimulated with OA **(A)** or linoleic acid (LA) **(B)**. \*\*\*\**p* \< 0.0001 compared with OA treatment alone. Representative images from four independent experiments of PMN treated with NF449 and stimulated with OA **(C)** or LA **(C)**. *n* = 4.](fvets-07-00260-g0006){#F6}

Beta-Oxidation Has a Role in OA-Triggered NET Induction
-------------------------------------------------------

To determine whether OA and LA metabolism affects the production of NETs, we exposed PMN to etomoxir, an inhibitor of CPT-1, a key enzyme in the mitochondrial beta oxidation of fatty acids. We showed that etomoxir treatment partially decreased NET formation triggered by OA ([Figure 7A](#F7){ref-type="fig"}) or LA ([Figure 7B](#F7){ref-type="fig"}). In agreement with this, we observed a partial reduction in the number of NET-like structures decorated with H4Cit3 when the PMN were exposed to etomoxir and then treated with OA or LA ([Figure 7C](#F7){ref-type="fig"}). Combined, the above results suggest that inhibition of the metabolic pathways of both fatty acids contributes to final NET release in OA- or LA-exposed PMN.

![Etomoxir partially blocks non-esterified fatty acid (NEFA)-induced neutrophil extracellular trap (NET) formation. Bar graph (means ± S.E.M.) of cell-free (cf)-DNA of PMN treated with 10 μM etomoxir for 60 min and stimulated with oleic acid (OA) **(A)** or linoleic acid (LA) **(B)**. Representative image from four independent experiments of PMN treated with etomoxir and stimulated with OA or LA **(C)**. *n* = 4; \*\**p* \< 0.01 compared with OA or LA treatment alone.](fvets-07-00260-g0007){#F7}

Discussion {#s4}
==========

In this study, we evaluated whether NEFAs could induce NET release in bovine PMN and found that OA and LA can induce the formation of NETs staining positive for H4Cit3. This histone citrullination was previously described in NETs induced by D-lactate in bovine PMN ([@B36]), and is a key mechanism in NET production ([@B37]). A previous study indicated that OA at 17.7 μM (0.5 μg/0.1 ml) induces NET formation after 240 min of stimulus in human PMN ([@B38]). NET formation is also induced in mouse bone marrow--derived PMN stimulated with LA at 50 μM for 240 min ([@B39]). However, this response to OA and LA treatment was faster in bovine PMN (30 min). The formation of NETs in PMN was initially described as an effective antimicrobial mechanism that leads to the death of pathogens trapped within this extracellular DNA mesh ([@B40]). However, excessive NET production, especially surrounding healthy tissues, is harmful to the host and can lead to aseptic inflammatory processes ([@B41], [@B42]). Consequently, NETs were proposed to play both protective and pathogenic roles ([@B43]). In cattle and sheep, the presence of NETs has been observed in milk and the mammary gland ([@B44], [@B45]). On the other hand, the increase in NETs produces a cytotoxic effect on bovine mammary gland epithelial cells (BMECs) ([@B46]). These results have revealed that the increase in NETs contributes to the damage of BMECs associated with mastitis in bovine ([@B46]). In the uterus, there is a substantial influx of neutrophils after calving (around 40% PMN in cytology at day 7 postpartum) ([@B47]), in which one was exposed to high levels of NEFAs, thus with a reduced capacity of ROS production and NETs formation ([@B48], [@B49]), and the heifers are prone to acquire infectious diseases such as metritis and mastitis. Our results support the fact that NEFAs contribute to the increase in NETs, which is associated with a higher incidence of inflammatory diseases during the peripartum period in cattle.

Previous studies have indicated that the serum NEFAs concentrations reach values between 0.7 mM ([@B5], [@B50]) and 1.5 mM ([@B4]) approximately. Likewise, the percentage of OA and LA from serum total NEFAs fluctuates between 10 and 15% and between 26 and 40%, respectively, during bovine peripartum ([@B5]); thus, the OA and LA concentrations in peripartum with a high level of NEFAs (1.5 mM) could be between 150 and 225 μM and between 390 and 600 μM, respectively. The main limitation of NEFAs is linked to their very low aqueous solubility; hence, in *in vitro* studies, albumin can be added to partially bind to NEFAs to improve aqueous solubility. The fraction of unbound NEFAs accessible for cellular uptake depends on the ratio of total NEFAs to albumin ([@B51]). Therefore, the albumin concentration used may be critical in the biological effects of the FFA in *in vitro* studies. Furthermore, the affinity of the FFA for albumin will determine the concentrations of the unbound FFA and hence the effects observed ([@B52]). Despite the above, the molar ratio of FFA/albumin is often not reported, making it difficult to determine the proper concentration to obtain FFA-free levels for each *in vitro* model ([@B51]). Moreover, changes in albumin concentrations have been reported to influence the biological effects of the FFA ([@B51]). Nonetheless, in this work, the objective was to explain the mechanisms of the unbound FFA on the release of NETs; for this reason, we did not use albumin. However, it will be of great interest to evaluate these effects of the FFA in the presence of albumin in the near future to be as close as possible *in vivo*.

NET formation is known to be dependent on NADPH oxidase complex activation and ROS production ([@B53]). Moreover, OA and LA are reported to induce ROS production in bovine PMN through FFA1 activation ([@B14], [@B15]). However, we demonstrated that OA- and LA-induced NET formation was independent of FFA1 and NADPH oxidase activation, as treatment with GW1100 (FFA1 inhibitor) and DPI (NADPH oxidase inhibitor) did not reduce the levels of NEFA-mediated NET formation.

Previous studies have shown that treatment with OA and LA leads to increased ROS production in bovine PMN ([@B14]), while treatment with GW1100 results in decreased NEFA-induced ROS generation ([@B15]). Furthermore, NADPH oxidase inhibition by DPI also reduces NET formation induced by *Cryptosporidium parvum* ([@B54]), *Ostertagia ostertagi*, and PMA ([@B55]). *Leishmania* ([@B56]) and the calcium ionophore A23187 ([@B57]) have been reported to induce early NET formation *via* a ROS-independent mechanism, as has been the activation of SK3 potassium channels present on mitochondria ([@B57]).

Intense lipid mobilization from tissue stores is an essential metabolic adaptation during the transition period that results in a significant release of NEFAs into the bloodstream ([@B2]). Moreover, at 3 days postpartum in dairy cows, Seo et al. ([@B24]) demonstrated that PMN exhibit increased expression of PANX1 ([@B24]), a hemichannel involved in PMN-derived ATP release ([@B22], [@B58]). These observations suggest that, in this period, PMN can increase the extracellular ATP level *via* PANX1. We corroborated the presence of PANX1 in bovine PMN and further found that the NEFA-induced ATP release was inhibited by CBX, supporting a role for PANX1 in this innate immune response. Xiao et al. ([@B25]) demonstrated that palmitic acid induces ATP release via PANX1 in liver cells under hepatic inflammation and injury ([@B25]).

The ATP released into the extracellular space can serve as a messenger molecule that facilitates communications between adjacent cells ([@B21]). Moreover, an increase in ATP levels can act as a proinflammatory signal ([@B59]) and can also be classified as a "damage-associated molecular pattern" (DAMP) ([@B60], [@B61]). In connection with the above, extracellular ATP can function as an autocrine signaling molecule through the activation of purinergic receptors, as previously proposed ([@B22]).

Recently, PANX1-mediated ATP release from bone marrow--derived murine PMN was indicated to contribute to NET release independently of NADPH oxidase ([@B62]). Similarly, we demonstrated that CBX treatment reduced NEFA-induced NET formation, suggesting that ATP can act as an extracellular signal for NEFA-induced NET formation in bovine PMN.

ATP is a ligand for purinergic receptor family members in the innate immune system ([@B60]). The purinergic receptors P2X1, P2X4, P2X5, and P2X7 were shown to be expressed in both human ([@B60], [@B63]) and rat PMN ([@B64]). We found that these receptors were similarly expressed in bovine PMN, with P2X1 and P2X4 showing the highest expression levels. P2X receptors comprise a seven-member family (P2X1--7) of cation (Na^+^, K^+^, and Ca^2+^) channel receptors with differing functions in immune cells ([@B65]). In human PMN, P2X1 is involved in migration, degranulation, and phagocytosis ([@B66]). Other authors have clearly shown that P2X1 activation in neutrophils induces increased membrane expression of CD11b thereby promoting neutrophil migration from blood vessels into tissues ([@B58], [@B67]). Furthermore, it has been shown that activation of P2X1 by extracellular ATP can improve random migration of PMN through Rho kinase signaling ([@B66]). In addition to the above-mentioned, activation of P2X1 by ATP increases the entry of calcium in neutrophils ([@B58]). Transient calcium increase is necessary for neutrophil activation and exocytosis of cytosolic granules. Additionally, a recent study indicated that LPS-induced ATP release activates the release of secretory vesicles, tertiary granules, and secondary granules in autocrine form through P2X1 activation ([@B66]). Also, an efficient NETs formation required extra- and intracellular calcium mobilization ([@B68]). Finally, P2X1 activation has recently been involved in protozoan parasites *Besnoitia besnoiti* and *Neospora caninum*--induced NETosis in the bovine system ([@B69], [@B70]) proving its crucial role in PMN activation. P2X4 has been reported with a role in polarization, pseudopod formation, and migration of human T cells ([@B71]). However, it was not known whether P2X4 has a role in PMN function. Here, we showed that only P2X1 inhibition could reduce NET formation triggered by NEFAs.

As the NEFA-induced NET formation was independent of FFA1, other mechanisms may be involved, such as metabolic modulation. It well is known that PMN possess a highly developed mitochondrial network that is required for cellular processes such as chemotaxis and maintenance of cell shape and contribute to respiratory burst ([@B72]). Through FAO, NEFAs are broken down in peroxisomes or mitochondria to generate Acetyl-CoA, a metabolite that enters the tricarboxylic acid cycle or Krebs cycle to obtain ATP ([@B73], [@B74]), and this could be a source of ATP that could be released. Another source of ATP release is finely controlled by diffusion through plasmalemmal channels from exocytotic release from ATP-rich vesicles ([@B75]). Also, under extreme conditions, such as trauma, ischemia, and infection, cellular necrosis will release vast amounts of ATP from intracellular storage pools ([@B76]). Under basal conditions, mitochondria contribute mainly to cell death (apoptosis) and not contribute to energy metabolism in human PMN ([@B20]). However, Bao et al. ([@B21]) demonstrated that mitochondria regulate PMN activation by ATP production for autocrine signaling ([@B21]). In connection with the above, OA and LA can induce lipid droplet formation in beta-pancreatic cells ([@B77]) and human hepatic cells (Huh-7) ([@B78]). Besides, in a cell with a high metabolic rate like brown adipose tissue, it was found that mitochondria are associated to lipid droplet and increased pyruvate oxidation, electron transport, and ATP synthesis capacities ([@B79]), which one could be contributing to ATP release. It was recently proposed that fatty acids are metabolized by mitochondria through beta-oxidation and used as an energy source during PMN differentiation ([@B80], [@B81]).

We found that etomoxir, a beta-oxidation inhibitor, partially reduced NEFA-induced NET formation. This suggests that this metabolic pathway may contribute to NET release. Undifferentiated PMN show abundant lipid stores and increased FAO that may be critical for the supply of sufficient ATP for energy-demanding processes ([@B80]). Etomoxir was reported to partially block NET formation in immature rodent PMN ([@B82]), indicating that FAO contributes to the formation of NETs in PMN but may not be the only fuel source for this response.

In conclusion, we showed that NEFAs induce NET formation through PANX1-mediated ATP release and activation of P2X1 in bovine PMN. This phenomenon could explain the changes observed during the transition period of dairy cattle, characterized by elevated concentrations of NEFAs, disruption of immune and inflammatory functions, and appearance of postpartum diseases.
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Bar graph (means ± S.E.M.) of cell-free (cf)-DNA of PMN treated with different concentrations of NF449 (potent and selective antagonist of the P2X1 receptor) **(A)** or 5-BDBD (P2X4 antagonist) **(B)** of A804598 (P2X7 antagonist) **(C)** and stimulated with OA. *N* = 4; ^\*\*^*p* \< 0.01, ^\*\*\*\*^*p* \< 0.0001 compared with OA treatment alone.
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